141 related articles for article (PubMed ID: 9399670)
1. Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells.
Ricchi P; Pignata S; Di Popolo A; Memoli A; Apicella A; Zarrilli R; Acquaviva AM
Int J Cancer; 1997 Dec; 73(6):880-4. PubMed ID: 9399670
[TBL] [Abstract][Full Text] [Related]
2. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation.
Park JH; Corkins MR; Vanderhoof JA; Caruso NM; Hrbek MJ; Schaffer BS; Slentz DH; McCusker RH; MacDonald RG
J Cell Physiol; 1996 Feb; 166(2):396-406. PubMed ID: 8592000
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and differentiation of the human colon carcinoma cell line, Caco-2, by constitutive expression of insulin-like growth factor binding protein-3.
MacDonald RG; Schaffer BS; Kang IJ; Hong SM; Kim EJ; Park JH
J Gastroenterol Hepatol; 1999 Jan; 14(1):72-8. PubMed ID: 10029281
[TBL] [Abstract][Full Text] [Related]
4. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.
Shiff SJ; Qiao L; Tsai LL; Rigas B
J Clin Invest; 1995 Jul; 96(1):491-503. PubMed ID: 7615821
[TBL] [Abstract][Full Text] [Related]
5. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.
Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S
J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258
[TBL] [Abstract][Full Text] [Related]
6. Constitutive insulin-like growth factor-II expression interferes with the enterocyte-like differentiation of CaCo-2 cells.
Zarrilli R; Romano M; Pignata S; Casola S; Bruni CB; Acquaviva AM
J Biol Chem; 1996 Apr; 271(14):8108-14. PubMed ID: 8626497
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis.
Shiff SJ; Koutsos MI; Qiao L; Rigas B
Exp Cell Res; 1996 Jan; 222(1):179-88. PubMed ID: 8549662
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells.
Shao J; Fujiwara T; Kadowaki Y; Fukazawa T; Waku T; Itoshima T; Yamatsuji T; Nishizaki M; Roth JA; Tanaka N
Oncogene; 2000 Feb; 19(6):726-36. PubMed ID: 10698490
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells.
Goel A; Chang DK; Ricciardiello L; Gasche C; Boland CR
Clin Cancer Res; 2003 Jan; 9(1):383-90. PubMed ID: 12538492
[TBL] [Abstract][Full Text] [Related]
10. TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.
Heijink DM; Jalving M; Oosterhuis D; Sloots IA; Koster R; Hollema H; Kleibeuker JH; Koornstra JJ; de Vries EG; de Jong S
J Pathol; 2011 Feb; 223(3):378-89. PubMed ID: 21171083
[TBL] [Abstract][Full Text] [Related]
11. Effect of the nonsteroidal anti-inflammatory drug indomethacin on proliferation and apoptosis of colon carcinoma cells.
Kralj M; Kapitanović S; Kovacević D; Lukac J; Spaventi S; Pavelić K
J Cancer Res Clin Oncol; 2001; 127(3):173-9. PubMed ID: 11260862
[TBL] [Abstract][Full Text] [Related]
12. Ornithine decarboxylase and diamine oxidase in human colon carcinoma cell line CaCo-2 in culture.
D'Agostino L; Daniele B; Pignata S; Gentile R; Tagliaferri P; Contegiacomo A; Silvestro G; Polistina C; Bianco AR; Mazzacca G
Gastroenterology; 1989 Oct; 97(4):888-94. PubMed ID: 2506100
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle block at G1-S or G2-M phase correlates with differentiation of Caco-2 cells: effect of constitutive insulin-like growth factor II expression.
Zarrilli R; Pignata S; Apicella A; Di Popolo A; Memoli A; Ricchi P; Salzano S; Acquaviva AM
Gastroenterology; 1999 Jun; 116(6):1358-66. PubMed ID: 10348819
[TBL] [Abstract][Full Text] [Related]
14. Effect of non-steroidal anti-inflammatory drugs on colon carcinoma Caco-2 cell responsiveness to topoisomerase inhibitor drugs.
Ricchi P; Di Matola T; Ruggiero G; Zanzi D; Apicella A; di Palma A; Pensabene M; Pignata S; Zarrilli R; Acquaviva AM
Br J Cancer; 2002 May; 86(9):1501-9. PubMed ID: 11986787
[TBL] [Abstract][Full Text] [Related]
15. Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells.
Babbar N; Gerner EW; Casero RA
Biochem J; 2006 Feb; 394(Pt 1):317-24. PubMed ID: 16262603
[TBL] [Abstract][Full Text] [Related]
16. Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonic Caco-2 cells. Status of the pRb1 and pRb2 tumor suppressor gene products.
Djelloul S; Forgue-Lafitte ME; Hermelin B; Mareel M; Bruyneel E; Baldi A; Giordano A; Chastre E; Gespach C
FEBS Lett; 1997 Apr; 406(3):234-42. PubMed ID: 9136893
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-11-keto-beta-boswellic acid (AKBA) prevents human colonic adenocarcinoma growth through modulation of multiple signaling pathways.
Yuan Y; Cui SX; Wang Y; Ke HN; Wang RQ; Lou HX; Gao ZH; Qu XJ
Biochim Biophys Acta; 2013 Oct; 1830(10):4907-16. PubMed ID: 23850473
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin-independent effects of aspirin on cell cycle and putrescine synthesis in human colon carcinoma cells.
Eklou-Kalonji E; Andriamihaja M; Reinaud P; Mayeur C; Camous S; Robert V; Charpigny G; Blachier F
Can J Physiol Pharmacol; 2003 May; 81(5):443-50. PubMed ID: 12774850
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
